尾酒细胞重编程的水凝微球实现无痕的毛囊再生
Shuaifei Ji1, Yingying Li1, Lei Xiang2
1Research Center for Tissue Repair and Regeneration affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College, PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair and Regeneration, Research Unit of Trauma Care, Tissue Repair and Regeneration, Chinese Academy of Medical Sciences, 2019RU051, Beijing, 100048, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 16, 2024
概括
这项研究引入了人工毛囊播种 (AHFS) 微球,该微球使用化学尾酒将纤维细胞重新编程为皮肤乳头细胞,促进皮肤伤口愈合和毛囊再生.
科学领域:
- 再生医学是一种再生医学.
- 生物材料科学 生物材料科学
- 皮肤病学 皮肤病学
背景情况:
- 痕修复通常会损害皮肤功能,导致毛囊损失.
- 同时解决痕形成和诱导毛囊再生是伤口愈合的一个重大挑战.
研究的目的:
- 通过诱导毛囊在位再生来开发一种功能性皮肤修复的新策略.
- 为了确定一种能够将纤维细胞重新编程成皮肤乳头细胞的化学尾酒.
- 设计基于生物材料的微球,以控制分娩和改善治疗结果.
主要方法:
- 使用Tideglusib和tamibarotene尾酒的化学重编程,将纤维细胞转化为皮肤乳头细胞 (DPC).
- 制造人工毛囊播种 (AHFS) 水凝微球使用脂质体纳米粒子,光响应水凝,聚胺修饰,微流体和光交联.
- 在体外和体内评估AHFS在伤口愈合,痕抑制和毛囊再生方面的有效性.
主要成果:
- 通过激活PI3K/AKT通路,AHFS成功诱导了纤维细胞-DPC重编程.
- 治疗促进了伤口愈合和毛囊在位再生.
- 痕形成显著受阻,表明一种双重的治疗方法.
结论:
- AHFS为功能性皮肤修复提供了一种有效的策略,它既解决了伤口愈合和附属体再生问题.
- 化学重编程和先进生物材料的结合为治疗皮肤损伤提供了一个有希望的方法.
- 这种方法有助于毛囊在现场再生,在受伤后恢复皮肤附属物.
相关概念视频
Multipotency and Niche of Bulge Stem Cell
3.6K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
3.6K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


